Chlorhexidine Gluconate, Miconazole Nitrate

Verify with FDA CVM →

13 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
13
Total Reports
0
Deaths Reported
0.0%
Death Rate

Active Ingredients

Chlorhexidine Gluconate, Miconazole Nitrate

Administration Routes

TopicalAuricular (Otic)

Species Affected

Dog 12
Cat 1

Most Affected Breeds

Retriever - Labrador 2
Terrier - Bull - Staffordshire 2
Terrier - Bull - American Pit 2
Beagle 1
Dog (unknown) 1
Crossbred Canine/dog 1
Shih Tzu 1
Havanese 1
Dog (other) 1
Domestic Shorthair 1

Most Reported Reactions

Lack of efficacy - NOS 7
Skin scab 3
Loss of hearing 3
Pyoderma 2
Localised pain NOS (see other 'SOCs' for specific pain) 2
Behavioural disorder NOS 2
Diarrhoea 2
Abdominal discomfort 2
Straining to defecate 2
Lethargy (see also Central nervous system depression in Neurological) 2
Neutrophilia 2
Eosinopenia 2

Outcome Breakdown

Outcome Unknown
8 (61.5%)
Ongoing
3 (23.1%)
Recovered/Normal
1 (7.7%)
Recovered with Sequela
1 (7.7%)

Data Summary

Metric Value
Total adverse event reports 13
Reports involving death 0
Case-fatality rate (reported events) 0.0%
Distinct species in reports 2
Distinct breeds in reports 10
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Chlorhexidine Gluconate, Miconazole Nitrate Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 13 adverse event reports referencing Chlorhexidine Gluconate, Miconazole Nitrate, including 0 reports in which the animal died — a 0.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Chlorhexidine Gluconate, Miconazole Nitrate. Reported administration routes include Topical, Auricular (Otic). These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Chlorhexidine Gluconate, Miconazole Nitrate reports are Dog (12 reports), Cat (1 reports), with Dog accounting for the largest share. Within those species, Retriever - Labrador (2), Terrier - Bull - Staffordshire (2), Terrier - Bull - American Pit (2) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Chlorhexidine Gluconate, Miconazole Nitrate are Lack of efficacy - NOS (7), Skin scab (3), Loss of hearing (3), Pyoderma (2). Of the 13 reports with a coded outcome, Outcome Unknown is the leading category at 61.5%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Chlorhexidine Gluconate, Miconazole Nitrate.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial